NCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Recruiting
Not specifiedUp to 21ObservationalDuke UniversityInvestigator-initiated
~20,000 participants
Updated 2026-08-27 on ClinicalTrials.gov
At a glance
Recruiting sites
69 of 82 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prospectively collect essential data elements from children, adolescents and young adults with pediatric rheumatic diseases
Measured over Approximately 10 years
+1 more outcome measured
Conditions
Where it's being run
82 sites across 41 statesNew York7
Ohio6
California5
Florida4
Massachusetts4
New Jersey4
North Carolina4
Pennsylvania4
Study leadership
- Mara L Becker, MD, MSCE · PRINCIPAL_INVESTIGATOR · Duke Clinical Research Insitute
- Mary Beth Son, MD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
- Timothy Beukelman, MD, MSCE · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Prospectively collect essential data elements from children, adolescents and young adults with pediatric rheumatic diseasesApproximately 10 years
- Evaluate the safety of therapeutic agents in persons with pediatric onset rheumatic diseasesApproximately 10 years